Senseonics Holdings (SENS) Liabilities and Shareholders Equity (2014 - 2026)

Senseonics Holdings' (SENS) quarterly Liabilities and Shareholders Equity came in at $102.9 million in Q1 2026, up 17.94% year-on-year from $87.2 million in Q1 2025, and down 18.54% on a QoQ basis from $126.3 million in Q4 2025.

Senseonics Holdings (SENS) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends

Senseonics Holdings (SENS) has 13 years of Liabilities and Shareholders Equity data on file, last reported at $102.9 million in Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 17.94% year-over-year to $102.9 million in Q1 2026; TTM through Mar 2026 was $519.3 million, a 31.29% increase from a year earlier, with the FY2025 full-year figure at $126.3 million, up 25.72% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $102.9 million, down from $126.3 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for SENS reached as high as $188.1 million in Q1 2022 and fell as low as $87.2 million in Q1 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $139.4 million across 5 years, with a median of $139.9 million in 2025.
  • Across the five-year window, Liabilities and Shareholders Equity tumbled 37.47% in 2024 and soared 45.25% in 2025, its largest moves.
  • Year by year, Liabilities and Shareholders Equity stood at $177.7 million in 2022, then decreased by 22.21% to $138.2 million in 2023, then decreased by 27.33% to $100.4 million in 2024, then increased by 25.72% to $126.3 million in 2025, then dropped by 18.54% to $102.9 million in 2026.
  • Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $102.9 million in Q1 2026, $126.3 million in Q4 2025, and $139.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 110.43 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 46.29 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 13.32 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 6.63 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 31.92 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 37.13 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 10.46 Bn
10 Senseonics Holdings 203.54 Mn 139.22 Mn 6.94 Mn 102.86 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 102.86 Mn
Dec 31, 2025 126.27 Mn
Sep 30, 2025 139.92 Mn
Jun 30, 2025 150.27 Mn
Mar 31, 2025 87.21 Mn
Dec 31, 2024 100.44 Mn
Sep 30, 2024 96.33 Mn
Jun 30, 2024 111.56 Mn
Mar 31, 2024 126.52 Mn
Dec 31, 2023 138.22 Mn
Sep 30, 2023 154.07 Mn
Jun 30, 2023 153.36 Mn
Mar 31, 2023 158.53 Mn
Dec 31, 2022 177.67 Mn
Sep 30, 2022 182.67 Mn
Jun 30, 2022 175.33 Mn
Mar 31, 2022 188.10 Mn
Dec 31, 2021 198.93 Mn
Sep 30, 2021 219.62 Mn
Jun 30, 2021 235.13 Mn